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ABSTRACT: A field examination on the chloroquine sensitivity of Plasmodium falciparum
in acute infections was carried out in the Iwahig Penal Colony of Palawan Island, the
Philippines, during the periods of September, 1971, to January, 1972, and of January to
February, 1973. The standard chloroquine dosage to subject patients was 25 mg base/kg
body-weight over 3 days and the follow-up examination for the parasites was made for
17 days (Day 0 to Day 16) on the subjects who were kept admitted in the medical
units established in the survey area. Results obtained were as follows: (1) The recru-
descence of asexual parasites was found in 44 (RI in 40, RII in 4) of 90 subjects
examined (48.9%). Five RI recrudescences were additionally detected among 18
subjects who were examined during the shortened follow-up period. (2) To the 44 recru-
descing patients, 35 mg chloroquine base/kg over 3 days was administered and 6 (RI in
5, RII in 1) of them exhibited recrudescence again, (3) In relation to the RI recrudes-
cence cases to the standard dosage of chloroquine, the detection of the earliest recrudes-
cence was done on Day 6 and the number of the detection of recrudescences on each day
thereafter tended to increase as days passed until the end of the follow-up period. (4)
In the number of days until the initial clearance of asexual parasitaemia from the begin-
ning day of chloroquine administration, no significant difference was found between two
groups of the RI recrudescence cases and the cured cases. (5) From the results obtained,
it could be concluded that the falciparum strains resistant to chloroquine had distributed
in the area of the Iwahig Penal Colony.
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Since the 4-aminoquinoline derivertives were known as drugs with the most effec-
tive schizontocidal activity to malaria parasites, they have been broadly used everywhere
in the endemic areas of malaria fortreatment as well as prophylaxis of the disease. As
a matter of fact, the malaria control measure in many areas has achieved a great success
by use of this series of antimalarials. On the other hand, the developmant of the malar-
ia strains resistant to the drugs has given us a serious problem. Up to the present
time, a clear evidence for the existence of the 4-aminoquinoline-resistant falciparum
strains has been presented from many areas in Southeast Asia, and Central and South
Americas.
In the Philippines, the resistant strains of Plasmodium falciparum to chloroquine
or amodiaquine were found in patients with acute infection in the Iwahig Penal Colony of
Palawan Island by Ramos et al. (1971); at Montalban, a town near Manila, by Clyde et
at. (1971); and in the Manila area by Shute et al. (1973).
This field survey was undertaken to examine on the response of P. falciparum to
chloroquine in prisoners (colonists) with acute falciparum infection in the Iwahig Penal
Colony. This colony has been well known as a malarious area in the country (Alves et
aL, 1968; Ramos et aL, 1971; Cabrera et al., 1972; Nakabayashi et al., 1973). As the
result, many recrudescence cases to the standard dosage of chloroquine were found,
which could be an evidence for the possible existence of the chloroquine-resistant falci-
parum strains in the area.
This survey was conducted in cooperation with members of the Malaria Eradication
Service, Department of Health, Republic of the Philippines.
SURVEY TIME
The survey was done in 2 separate times : the 1st time was the period from Sep-
tember, 1971, to January, 1972, and the 2nd, January and February, 1973.
SURVEY AREA ANDSUBJECTS
The Iwahig Penal Colony selected as an area for this survey was located in the
central part of Palawan Island and had approximately 4,000 colonists in an area of about
390 square kilometers. Palawan Island is slender in form and mountainous, and is situat-
ed between the South China Sea and the Sulu Sea in the southwesternmost portion of the
Philippines. This island has been designated by the Philippine Government as a priority
area for malaria control, because it has shown\ the highest malaria endemicity as com-
pared with other areas of the country. Geographical and climatic circumstances of the
island were previously stated by Nakabayashi et aL (1973).
Colonists were each assigned to a section or unit in one of the following 5 subcolo-
nies ; Central, Montible, Santa Lucia, Bagong Buhay, and Inagawan, and engaged in a
forced labor. The 1st time of survey was conducted at the Iwahig General Hospital estab-
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lished in the Central Subcolony, All the doors and windows of a big room of the hos-
pital were covered with nylon meshes to prevent mosquitoes from flying into the room
and all subjects were received in the room throughout the examination period. Acute
falciparum patients to be examined were selected from outpatients who were mostly sent
from the Central and Montible Subcolonies. In the 2nd, patients with acute falciparum
infection among colonists of the Montible Subcolony were confined in the Montible Infir-
mary for the examination of chloroquine senstivity.
All patients desirous of consultation were applied to a blood examination for malar-
ia parasites. The relative count of asexual parasites enumerated in a thick blood-film
with a microscope (magnification: x500) was signed according to the following code:
+ : 1-10 parasites per 100 fields ++ : ll-100 parasites per 100 fields
+++ : 1-10 parasites per field -f+++ : more than 10 parasites per field
When necessary to ask the accurate expression of a parasite count with a thick film, it
was calculated by the way as described below:
First : the number of parasites was counted in each field against the number of
leukocytes in such a field until the leukocyte number reached 100 to 500.
Second: the number of parasites was calculated in relation to the number of leuko-
cytes per cubic millimeter which wTascounted beforehand with a haemocytometer.
Among falciparum patients, those having the clinically serious or parasitologically
intense symptoms, and showing such a small parasite count as one parasite in some dozen
fields of a thick film, were excluded from the subjects. Regardless the grade of parasi-
taemia, patients who complained of frequent vomiting were excepted, as a rule.
The subject patients thus finally selected had the parasite count over the higher
grade of the "one plus", and most of them showed 38°C or higher fever and also com-
plained of chills or the chill sensation at the time of the blood examination. The number
of subjects was 90in total; 34inthe 1st time of survey and 56 in the 2nd. They all
were males of more than 18 years.
CHLOROQUINE DOSAGE AND METHOD OF EXAMINATION
Chloroquine diphosphate tablets used in this survey were Rezochin (Bayer) and
Aralen (Park Davis) which contained 150 mg base per tablet. The dosage to a patient
was 25 mg chloroquine base per kilogram body-weight over 3 days according to the
standard regimen which had been recommended by the WHO Expert Committee (1968)
for a field test on the chloroquine sensitivity of P. falciparum in patients. The daily
doses were decided to be 10 mg/kg first and 5 mg/kg 6 hours later on the first day (Day
0), and 5 mg/kg on the second (Day 1) and the third (Day 2) respectively, based on the
descriptions by Covell et al. (1955) and WHO (1967), and on the authors' previous
experience.
The follow-up examination for malaria parasites was made every day for 10 days
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〔Day 0 to Day　9〕, and on Day 12　and
Day 16. The total follow-up period was
shortened to 17 days 〔Day 0 to Day 16〕
due to various circumstances, though a
28-day examination was recommended for
this test by WHO (1968〕 and others. The
=
urine test for chloroqume estimation was
failed to be done. The schematic proce-
dure of the examination was indicated in
Fig. 1. Recrudescing patients to　25 mg
chloroqume/kg administration were treat-
ed again with　35 mg/kg dosage for the
■　　　　　●
purpose of examining on the response of
the parasites to the increased dosage of
the drug. For an expression of the recru-
descence of parasitaemia, 3 signs of RI,
RII, and RIII were employed in accord-
ance with a description by the WHO Expert Committee 〔1968). The daily doses of
●
chloroquine by body-weights were shown in Table 1.
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o :　B】ood examination
* : Examination continued, if necessary
Chloroquine diphoshate : Rezochin or Aralen, 150 mg base/tablet
Dosage : 25 mg chloroquine base/kg body-weight over 3 days
Fig. 1. Method of examination on chloroquine sensitivity of
falciparum parasites in patients with acute infection.
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RESULTS
1. Recrudescence of parasitaemia
A. Results in the lst time of survey
Of 34 patients administered orally the standard dosage 〔25 mg/kg〕 of chloroqume
over 3 days, ll exhibited recrudescence during the follow-up period. Thus the recrudes-
cence rate was　32.4 %. Other　23　were cured parasitologically as well as clinically
without recrudescence. Of the ll recrudescences, 10 were regarded as the RI type and
the rest 1 the RII. One of the RI cases was detected on Day 6 in the first week after
こ)
the chloroquine treatment, other　7 in the second week 〔Day 10 to i)ay 16〕∫　and the
remaining 1 on Day 20. The initial clearance of asexual parasitaemia was achieved in
2.8土0.9 days (mean and 95% confidence limits〕 in the 10 RI c∂ses紬ne who recrudesced
on Day 20 was omitted〕 and in 2.4土0.5 days in the 23 cured cases respectively. The ll
recrudescing patients were given 35 mg chloroquine/kg over 3 days and 2 of them showed
the RI recrudescence to the increased dosage.
In this field survey, 46 vivax patients were found and treated with the standard
dosage of chloroquine in combination with 15 mg primaquine base/day for 14 days. All
of them were cured within several days, showing a rapid clearance of parasitaemia and
had no recrudescence during the survey period.
The above-mentioned results were summarized in Table 2肝
Tab】 2.　Results of examination on chloroquine sensitivity of malaria parasites






























* : The number of days 〔mean and 95 % confidence limitsl
until the initial clearence of asexual parasitaemia
** : Including one who recrudesced on Day 20
*** : Recrudescing patients to 25 mg/kg of chloroquine
串*** : Combined with 15 mg primaquine base/day for 14 days
2.8土0.3
B. Results in the 2nd time of survey
To each of 56 acute falciparum patients, 25 mg chloroquine/kg was administered
over 3 days. The complete cure was observed in 23 patients but the recrudescence of
asexual parasitaemia was found in other 33, so the recrudescence rate was as high as
58･9%. TheRItype was found in 30 and the RII in therest 3. Threeofthe30RI
cases had the reappearance of asexual parasites in the peripheral blood in the first week
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〔Day 3 to Day 9〕 after the chloroquine treatment and 27 in the second week 〔Day 10 to
Day 16〕 The mean number of days from the lst day of血Ioroquine administration to
=
the initial clearance of asexual parasitaemia was 2.8土0.3 in the 30 RI cases and in the
23 cured cases as well. These results were shown in Table 2.
The 33 recrudescing patients were treated with 35 mg chloroquine/kg over 3 days
to examine on the response of falciparum parasites to the increased dosage of the drug.
Although the follow･up period had to be shortened due to the survey schedule, 4 recru-
descences 〔RI in 3, RII in l〕 could be found during the period from Day 9 to Day 16.
These recrudescences were described in the item of "Incomplete follow-up" of the table.
In this survey, 18 acute falciparum patients other than the above-described 56 were found
but the follow-up examination to them could not be done during the whole period until
Day 16, because of the lack of time, although 25 mg/kg of chloroquine was given to
them. Among them, however, 5 RI recrudescence cases could be observed, so they were
also listed in "Incomplet follow-up" of the same table.
2. The number of RI recrudescences on each day
Regarding a total of 45 RI cases, including 5 in the incomplete follow-up, to 2o
mg/kg of chloroquine obtained through the whole period of this survey, the number of
recrudescences was counted ea血day duri咽the follow一叩period. As indicated in Fig.
2, the detection of the earliest recrudescence was done in one case on Day 6, and there-
after the number of recrudescences showed a tendency of increase as days passed.
The mean number of days from the preceding ciearanc巳of asexual parasitaemia to
the detection of recrudescence was 10.1土1.0 〔95% con臼dence limits〕 in total of 44 Rl



















Mean number of days : 10.1土1.0*
* : The number of days (mean and 95% confidence limits) from the preceding
clearance of parasitaemia until the detection of recrudescence





Since Moor and Lanier first reported on chloroquine resistance in falciparum pa-
tients in 1961, though the observation was carried out in Colombia, South America in 1959,
many informations on this subject have been presented from Southeast Asia, and Central
and South Americas. In Southeast Asia, the first finding is thought to have been done
by Harinasuta et al, in 1962 in the central and south parts of Thailand, which was
reported in detail in 1965 by them. Since then, the distribution of the 4-aminoquinoline-
resistant falciparum strains has been recognized in Malaysia (Montgomery and Eyles,
1963; others), Cambodia (Eyles et al., 1963), and South Vietnam (Powell et «/., 1964;
others) in addition to Thailand. Further, in recent years, the similar findings were
reported from Laos (Ebisawa et at., 1970), Singapore (Ng et al., 1969; Paul et al.,
1971), Sumatora of Indonesia (Peters' monograph, 1970), the Philippines (Ramos et al. t
1971; Clyde, 1971; Shute et al., 1972), Burma (Clyde et al. 1972), and Sabah of Borneo
(Clyde et al.t 1973).
As for the drug resistance problem on malaria in the Philippines, Ramos et al,
(1971) pointed out that the chloroquine-resistant falciparum strains existed in the Iwahig
Penal Colony of Palawan Island, as they obtained the results that 2 of 20 subjects exhib-
ited the RI recrudescence in the Inagawan Subcolony in 1969 and 19 of 24 examinees also
had recrudescence (RII in one, RI in others) in the whole colony area in 1970 to 25 mg/
kg. Shute et al. (1972) noted the fact that a patient with the amodiaquine-resistant falci-
parum parasites detected in the Manila area had moved from Palawan Island.
In this survey, ll of 34 falciparum patients in the 1st time (1971-1972) and 33 of 56
in the 2nd (1973) were found to have recrudescence (RI in 40, RII in 4) to the standard
dosage (25 mg/kg over 3 days) of chloroquine. Judging from only this result, it was
easily accepted that the falciparum strains resistant or, at least, much less-sensitive to
chloroquine had distributed widely in the colony. On the other hand, the fact that a
retreatment with an increased dosage (35 mg/kg) of chloroquine to the recrudescing
patients could suppress the subsequent recrudescence in most of the patients, might pro-
vide us with some criteria on the cause of recrudescence. A possibility that some parasites
in patients might escape from the expected action of chloroquine could not be completely
removed. Administration of a more increased dosage of chloroquine than 35 mg/kg to
subjects was, in fact, hesitated for their physical condition. No difference was found in
the initial response of P. falciparum to the standard dosage of chloroquine between 2
groups of the RI recrudescence cases and the cured cases. This fact, however, was not
thought to have a significant meaning for estimating the chloroquine sensitivity of the
falciparum strains which exhibited the RI recrudescence. In this connection, it would be
preferable to conduct a single-dose examination with 10 mg/kg of chloroquine for a preli-
minary test, although the test could not be done due to the limited survey schedule. To
avoid misjudgement on the chloroquine sensitivity of the parasites, the so-called drug
failure, particularly vomiting of patients, was carefully checked throughout the examina-
tion period.
Although some criteria as mentioned above were left to the future examination,
the following results should be noticed: The total number of recrudescences to 25 mg/kg
of chloroquine obtained in this survey reached as many as 44 of 90 examinees (48.9%) in
which 4 cases of the RII type were included. Further, the fact that 6 recrudescences
(RI in 5, RII in 1) to 35 mg/kg of chloroquine could be observed among 44 recrudescing
patients to 25 mg/kg of it was to attract the authors' particular attention. Summarizing
the data obtained in this survey and the references in the similar field of study published
previously by several workers in the Philippines, it could be concluded that the falcipa-
rumstrains resistant to chloroquine had undoubtedly distributed in the area of the Iwahig
Penal Colony.
In addition, it was noticeable that patients with the parasites resistant to chloro-
quine could be completely cured by treatment with sulformethoxine or sulfamethoxypy-
razine, either alone or in combination with pyrimethamine.
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Isabelo S. DULAY, Jr., and Juan A. PURIRAN (Malaria Eradication Service, Department of
Health, the Philippines)
1971年9月より翌年1月まで,および1973年1, 2月の2回にわたり,フィリピン,パラワン島の
イワヒグ囚人部落(約390km2,約4,000人)において,熱帯熱マラリア患者を対象にして,クロ
ロキン耐性についての野外調査を実施した.クロロキンの標準投与量は25mg塩基量/kgとし,3
日間に分割,経口投与を行ない,原虫検査期間は17日間と定めた.得られた成績を総合すると次の
如くである.(1)原虫再燃は被検患者90人中44人(48.9%)に検出されそのうち40人はRI型を,
4人はRII型を示した.(2)上記RI再燃患者44人にクロロキン35 mg/kgを投与し,うち6人
(RI型5人,RII型1人)に再燃を認めた.(3) RI再燃の検出は,治療開始後6日目の1例がもっ
とも早期で,以後日数の経過と共に検出例数の増加が見られた.(4) PI再燃群と治癒群間には,無
性型原虫の血中より消失するまでの平均日数に有意差を認めなかった.(5)以上の成績から,本調査
地域にはクロロキン耐性熱帯熱原虫が分布しているものとの結論に達した.
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